Cancer Genetics, Inc, a DNA-based diagnostics company today announced an agreement to acquire BioServe Biotechnologies (India) Pvt Ltd for approximately $1.9 million. Under the terms of the agreement, BioServe India, headquartered in Hyderabad will become a subsidiary of CGI, based in New Jersey, US, and will be renamed Cancer Genetics India Pvt Ltd. CGI plans on retaining all 33 employees of BioServe India, and further expanding and strengthening the sales and clinical teams. CGI is focused on developing genomic-based oncology tests and services. The acquisition will primarily be in CGIX stock and other deferred consideration. The transaction is expected to close during the third quarter of 2014, a press release said. Our Bureau
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.